Literature DB >> 6178813

Development of hybridoma-produced antibodies directed against Eimeria tenella and E. mitis.

H D Danforth.   

Abstract

Hybridoma cell lines, which secreted antibodies directed against two different strains of Eimeria tenella and one strain of E. mitis, were produced by fusion of spleen cells from sporozoite-immunized Balb/cByJ mice with P3-X63-Ag8 myeloma cells. The antibodies demonstrated at least eight different binding patterns on or in air-dried sporozoites as determined by the indirect immunofluorescent antibody (IFA) test. These patterns varied from a general internal fluorescence similar to that seen with sporozoites exposed to hyperimmune chicken serum, to fluorescence observed on the tip, pellicle, and refractile body of the parasite. Five cloned, antibody-secreting cell lines were successfully established. Four of these clones produced antibody that reacted only with various strains of E. tenella and cross-reacted with no other species of coccidia. The fifth clone produced antibody directed against only E. mitis and did not react with any other coccidial species.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6178813

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  3 in total

1.  Passive protection of chickens against Eimeria tenella infection by monoclonal antibody.

Authors:  M S Crane; P K Murray; M J Gnozzio; T T MacDonald
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

2.  In vitro and in vivo immunolabeling of sporozoites, schizonts, and sexual stages of Eimeria acervulina and E. tenella by a species- and stage-cross-reactive monoclonal antibody.

Authors:  H D Danforth; P C Augustine; J R Barta; M C Jenkins
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

3.  Characterization and immunoprotective properties of a monoclonal antibody against the major oocyst wall protein of Eimeria tenella.

Authors:  M J Karim; S C Basak; A J Trees
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.